Century Therapeutics Shares Trade Steady While Recent Filing Flags 176 Million Shares
Century Therapeutics stock traded flat ahead of the long U.S. holiday break. A new resale filing kept focus on possible stock overhang instead of the company’s latest trial data. Shares of the Philadelphia biotech were last at $2.26. Volume stood around 531,900, putting its market cap close to $437 million. That’s important since markets are closed for the weekend and Nasdaq will be shut again Monday, May 25, for Memorial Day. The next full session will be Tuesday. Investors will have until then to consider the company’s new SEC filing before trading starts up again.